Bioactive lipids and chronic inflammation: managing the fire within
V Chiurchiù, A Leuti, M Maccarrone - Frontiers in immunology, 2018 - frontiersin.org
Inflammation is an immune response that works as a contained fire that is pre-emptively
sparked as a defensive process during infections or upon any kind of tissue insult, and that …
sparked as a defensive process during infections or upon any kind of tissue insult, and that …
Bioactive lipids, inflammation and chronic diseases
A Leuti, D Fazio, M Fava, A Piccoli, S Oddi… - Advanced Drug Delivery …, 2020 - Elsevier
Endogenous bioactive lipids are part of a complex network that modulates a plethora of
cellular and molecular processes involved in health and disease, of which inflammation …
cellular and molecular processes involved in health and disease, of which inflammation …
Reviewing the significance of blood–brain barrier disruption in multiple sclerosis pathology and treatment
The disruption of blood–brain barrier (BBB) for multiple sclerosis (MS) pathogenesis has a
double effect: early on during the onset of the immune attack and later for the CNS self …
double effect: early on during the onset of the immune attack and later for the CNS self …
Ozanimod (RPC1063) is a potent sphingosine‐1‐phosphate receptor‐1 (S1P1) and receptor‐5 (S1P5) agonist with autoimmune disease‐modifying activity
FL Scott, B Clemons, J Brooks… - British journal of …, 2016 - Wiley Online Library
Background and Purpose Sphingosine1‐phosphate (S1P) receptors mediate multiple
events including lymphocyte trafficking, cardiac function, and endothelial barrier integrity …
events including lymphocyte trafficking, cardiac function, and endothelial barrier integrity …
Role of ceramide/sphingomyelin (SM) balance regulated through “SM cycle” in cancer
M Taniguchi, T Okazaki - Cellular signalling, 2021 - Elsevier
Sphingomyelin synthase (SMS), which comprises of two isozymes, SMS1 and SMS2, is the
only enzyme that generates sphingomyelin (SM) by transferring phosphocholine of …
only enzyme that generates sphingomyelin (SM) by transferring phosphocholine of …
Blood-brain barrier: more contributor to disruption of central nervous system homeostasis than victim in neurological disorders
M Xiao, ZJ Xiao, B Yang, Z Lan, F Fang - Frontiers in Neuroscience, 2020 - frontiersin.org
The blood-brain barrier (BBB) is a dynamic but solid shield in the cerebral microvascular
system. It plays a pivotal role in maintaining central nervous system (CNS) homeostasis by …
system. It plays a pivotal role in maintaining central nervous system (CNS) homeostasis by …
Fingolimod for the treatment of neurological diseases—state of play and future perspectives
R Brunkhorst, R Vutukuri, W Pfeilschifter - Frontiers in cellular …, 2014 - frontiersin.org
Sphingolipids are a fascinating class of signaling molecules derived from the membrane
lipid sphingomyelin. They show abundant expression in the brain. Complex sphingolipids …
lipid sphingomyelin. They show abundant expression in the brain. Complex sphingolipids …
Lipid metabolism in astrocytic structure and function
Astrocytes are the most abundant glial cell in the central nervous system and are involved in
multiple processes including metabolic homeostasis, blood brain barrier regulation and …
multiple processes including metabolic homeostasis, blood brain barrier regulation and …
The direct effects of fingolimod in the central nervous system: implications for relapsing multiple sclerosis
SF Hunter, JD Bowen, AT Reder - CNS drugs, 2016 - Springer
Fingolimod, a structural analog of sphingosine derived from fungal metabolites, is a
functional antagonist of the G-protein-coupled sphingosine 1-phosphate (S1P) receptors …
functional antagonist of the G-protein-coupled sphingosine 1-phosphate (S1P) receptors …
Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide
E Colombo, M Di Dario, E Capitolo… - Annals of …, 2014 - Wiley Online Library
Objective Although astrocytes participate in glial scar formation and tissue repair,
dysregulation of the NFκB pathway and of nitric oxide (NO) production in these glia cells …
dysregulation of the NFκB pathway and of nitric oxide (NO) production in these glia cells …